Home > Insider Trading > Filing (0001104659-11-012811)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411861	Mako Surgical Corp.	MAKO	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	201901148

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1398221	John Savarese	3000 Sand Hill Road Building #1, Suite 260 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-03-04	62,590	$20.00	2,283,122	No	4	S	Indirect	By Montreux Equity Partners IV. L.P.
Common Stock	Disposition	2011-03-07	44,453	$19.85	2,238,669	No	4	S	Indirect	By Montreux Equity Partners IV. L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Montreux Equity Partners IV. L.P.
No	4	S	Indirect	By Montreux Equity Partners IV. L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,719	Direct

Footnotes

The sale price of the 62,590 shares reported in this Form 4 was between the range of $20.25 per share and $19.90 per share, with a weighted average sale price of $20.003. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff, the Issuer or any security holder of the issuer upon request.
The reported securities are owned directly by Montreux Equity Partners IV, L.P. The voting and disposition of the shares held by Montreux Equity Partners IV, L.P. is determined by Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P. Mr. Savarese is a managing member of Montreux Equity Management IV, LLC. Mr. Savarese disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The sale price of the 44,453 shares reported in this Form 4 was between the range of $20.17 per share and $19.51 per share, with a weighted average sale price of $19.8478. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff, the Issuer or any security holder of the issuer upon request.